Research Reports

Declining growth rates in developed markets mean many pharmaceutical companies are turning their attention to developing markets.

Use this report to gain an understanding of the major drivers and resistors to generic growth in each of the 7 major markets.

Electronic health records (EHRs) will be the cornerstone of healthcare technology. The design, selection and implementation of EHRs, therefore, will be extremely important for healthcare institutions.

This report will analyse the future potential of new and emerging products from the medical device, pharmaceutical and biotechnology sectors, and measure their likely impact upon the existing market.

The medical establishment's approach to adherence is changing as it becomes clear that the responsibility of achieving adherence is not solely the patient's, but rather is shared among stakeholders. Learn how communication between patients, physicians and the pharmaceutical industry impacts rates of adherence.

Online pharmacies are playing an increasing role in the prescription pharmaceutical industry as patients seek the convenience and in some cases cost benefits that they can provide. However while online pharmacies offer considerable benefits there are also risks attached to their increasing role.

The roll-out of Part D in January 2006 represented a significant leap forward, since it provided coverage for outpatient drugs for Medicare patients for the first time. Gain a clear understanding of how Part D has evolved since its roll-out in January 2006 Understand the problems that Part D has faced, together with identifying areas for improvement Gain insight into the key issues that are shaping Part D currently and in the future

Technology has been used to either inform or expedite the prescribing process in most modern healthcare systems for over two decades. With this report, identify the dangers of the traditional paper-based prescribing model and how electronic prescribing can improve patient safety and compliance, and more.

The global diagnostics market is undergoing radical change; novel technologies driven by miniaturization and advances in genomics will enhance the role of diagnostics in the healthcare market, allowing more tests to be performed at the point-of-care and facilitating the shift towards personalized medicine. “Innovation in Diagnostics” examines the advances in the rapidly growing field of molecular technologies that are enabling personalized healthcare to move into mainstream medicine.

This is a new report providing analysis of the current and future market for women’s health drugs across all major indications. Forecasts are given based on current marketed portfolio, drivers and resistors of growth and R&D pipelines, enabling you to predict changes in the dynamics of the global women’s health market. Key indications covered in this report are osteoporosis, infertility, uterine fibroids, endometriosis, urinary incontinence and gynecological infections.